Mission Bay Capital Overview

  • Investor Type

  • Venture Capital

  • Status

  • Active

  • Professionals

  • 2

Professionals
  • Investments

  • 69

  • Portfolio

  • 30

  • Exits

  • 18

Exits

Mission Bay Capital General Information

Description

Founded in 2009, Mission Bay Capital is a venture capital firm based in San Francisco, California. The firm seeks to invest in early-stage bioscience companies.

Contact Information

Website
www.missionbaycapital.com
Year Founded
2009
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Accelerator/Incubator
Primary Office
  • 953 Indiana Street
  • San Francisco, CA 94107
  • United States
+1 (415) 000-0000

Mission Bay Capital Investments (69)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Symbiome (Personal Product) 30-Jun-2022 Seed Round 000 Personal Products Generating Revenue 0000000 00000000 00.0
0000000 0000000000 05-Jan-2022 00000 00000 0000 Drug Discovery Pre-Clinical Trials
0000000 0000000000 02-Nov-2021 00000 00000 0000 Drug Discovery Generating Revenue
00000 00000000000 19-Aug-2021 00000 00000 0000 Cultivation Generating Revenue
000000 00000 22-Jul-2021 00000 00000 0000 Food Products Startup
0000 000000000000 21-Jun-2021 0000 00000 00.000 Drug Discovery Generating Revenue 000000 000000 00.0
000000000 11-Jun-2021 00000 00000 0000 Drug Discovery Clinical Trials - Phase 1 0000000 00000000 00.0
000 (0000000000 00 29-Jan-2021 0000 00000 00.000 Laboratory Services (Healthcare) Generating Revenue
Symbiome (Personal Product) 14-Sep-2020 Early Stage VC 0000 Personal Products Generating Revenue
Dren Bio 11-Sep-2020 Early Stage VC 0000 Drug Discovery Pre-Clinical Trials
You’re viewing 10 of 69 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mission Bay Capital Exits (18)

Company Name Exit Date Exit Type Exit Size
Magnamosis 27-Sep-2021 Merger/Acquisition
00000000 000000000 26-Aug-2021 0000000 000000 00000
0000000 0000000000 23-Jul-2021 000 00000
000 (0000000000 00 30-Jun-2021 000000000000000000 0000
0000000 00000 26-Apr-2021 000 00 00000000
00000000 22-Apr-2021 000 00000
000000 00000000000 01-Feb-2021 000 00 00000000
000000 20-Jun-2019 000 00000
Bell Biosystems 01-Jun-2019 Out of Business
Alector 07-Feb-2019 IPO 00000
You’re viewing 10 of 18 exits. Get the full list »

Mission Bay Capital Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Mission Bay Capital‘s full profile, request access.

Request a free trial

Mission Bay Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Mission Bay Capital Team (18)

Name Title Deals Funds Boards Office
Vivian Dang Controller San Francisco, CA
Douglas Crawford Ph.D Founder & Managing Director 00 0 00 San Francisco, CA
Harold Selick Ph.D Venture Partner 0 0 San Francisco, CA
Peter Parker Venture Partner 00 0 0 San Francisco, CA
Robert Blazej Ph.D Partner 0 0 0 San Francisco, CA
You’re viewing 5 of 18 team members. Get the full list »

Mission Bay Capital Co-Investors (142)

Name With Exits Lead Partner Series Industry
Mission BioCapital 7 0 Series chart Industry bar
AbbVie Ventures 0 0 Series chart Industry bar
Dementia Discovery Fund 0 0 Series chart Industry bar
SV Health Investors 0 0 Series chart Industry bar
Amgen Ventures 0 0 Series chart Industry bar
You’re viewing 5 of 142 co-investors. Get the full list »